Gohr, K., Hamacher, A., Engelke, L. H., & Kassack, M. U. (2017). Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38. BMC Cancer.
Citación estilo ChicagoGohr, Katharina, Alexandra Hamacher, Laura H. Engelke, and Matthias U. Kassack. "Inhibition of PI3K/Akt/mTOR Overcomes Cisplatin Resistance in the Triple Negative Breast Cancer Cell Line HCC38." BMC Cancer 2017.
Cita MLAGohr, Katharina, Alexandra Hamacher, Laura H. Engelke, and Matthias U. Kassack. "Inhibition of PI3K/Akt/mTOR Overcomes Cisplatin Resistance in the Triple Negative Breast Cancer Cell Line HCC38." BMC Cancer 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.